Cyclerion Therapeutics (CYCN) Change in Account Payables (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Change in Account Payables of $18000.0 in Q3 2025, up 185.71% quarter-over-quarter from -$21000.0 in Q2 2025, and up 12.5% on a YoY basis from $16000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Change in Account Payables (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Change in Account Payables history runs 8 years deep, the most recent figure standing at $18000.0 for Q3 2025.
- In Q3 2025, Change in Account Payables rose 12.5% year-over-year to $18000.0; the TTM figure through Sep 2025 stood at $176000.0 (up 220.55% YoY), while the FY2024 annual figure was -$445000.0, up 74.89% from the prior year.
- Change in Account Payables was $18000.0 for Q3 2025 at Cyclerion Therapeutics, up from -$21000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.3 million in Q4 2022 to a low of -$2.1 million in Q2 2023.
- Historically, Change in Account Payables has averaged -$66894.7 across 5 years, with a median of $16000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables surged 1379.63% in 2022, then plunged 931.05% in 2023.
- A 5-year view of Change in Account Payables shows it stood at -$311000.0 in 2021, then surged by 526.05% to $1.3 million in 2022, then tumbled by 70.94% to $385000.0 in 2023, then tumbled by 77.66% to $86000.0 in 2024, then tumbled by 79.07% to $18000.0 in 2025.
- The last three Change in Account Payables figures came in at $18000.0 (Q3 2025), -$21000.0 (Q2 2025), and $93000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -9.42 Mn |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -91,000.00 |
| Jun 30, 2024 | -91,000.00 |
| Mar 31, 2024 | -456,000.00 |
| Mar 31, 2024 | -456,000.00 |
| Dec 31, 2023 | 385,000.00 |
| Dec 31, 2023 | 385,000.00 |
| Sep 30, 2023 | -1.05 Mn |
| Sep 30, 2023 | -1.05 Mn |
| Jun 30, 2023 | -2.06 Mn |
| Jun 30, 2023 | -2.06 Mn |